KAGAN-MODENA Asymmetric Oxidation

KAGAN-MODENA Asymmetric Oxidation Asymmetric oxidation of sulfides to chiral sulfoxides by chiral titanium complexes and hydroperoxide. 

Significant improvements in asymmetric oxidations were made by Modena and, especially, by Kagan, and their coworkers. Both groups used chiral peroxotitanium complexes patterned after the Sharpless reagent as the oxidants. 

Astra-Zeneca commercialized esomeprazole (the S enantiomer of omeprazole) obtained by asymmetric oxidation of pyrmetazole (Equation 28) in 2000, using a modified version of the Kagan-Modena protocol. Esomeprazole is an anti-ulcer medicine and one of the largest selling drugs worldwide. It is produced under very mild conditions in a multi tonne per year scale. 

There are several efficient methods available for the synthesis of homochiral sulfoxides [3], such as asymmetric oxidation, optical resolution (chemical or bio-catalytic) and nucleophilic substitution on chiral sulfinates (the Andersen synthesis). The asymmetric oxidation process, in particular, has received much attention recently. The first practical example of asymmetric oxidation based on a modified Sharpless epoxidation reagent was first reported by Kagan [4] and Modena [5] independently. With further improvement on the oxidant and the chiral ligand, chiral sulfoxides of >95% ee can be routinely prepared by these asymmetric oxidation methods. Nonetheless, of these methods, the Andersen synthesis [6] is still one of the most widely used and reliable synthetic route to homochiral sulfoxides. Clean inversion takes place at the stereogenic sulfur center of the sulfinate in the Andersen synthesis. Therefore, the key advantage of the Andersen approach is that the absolute configuration of the resulting sulfoxide is well defined provided the absolute stereochemistry of the sulfinate is known. 

Quite recently, new methods for the synthesis of chiral sulfoxides have been discovered. Asymmetric oxidation of sulfides by peroxides in the presence of chiral titanium catalysts has been studied by Kagan and Modena [S02-S0S] ( 3.2.3), and the use of chiral oxaziridines ( 2.8) as oxidizing agents has been introduced by Davis [506]. 

The asymmetric oxidation of sulfides represents a straightforward access to chiral sulfoxides that are useful compounds for asymmetric synthesis as chiral auxiliaries and also for the synthesis of biologically active molecules. Among the different methods to perform these reactions, titanium-mediated thioether oxidation is one of the most attractive. Indeed, Kagan ° and Modena independently showed that the use of chiral titanium complexes derived from Sharpless reagent allows the asymmetric oxidation of prochiral sulfides (Scheme 7.6). 

Oxidation in the presence of chiral titanium tartrate (modified Sharpless method). Inspired by the Sharpless asymmetric epoxidation48 of allylic alcohols with hydroperoxides in the presence of chiral titanium complex [diethyl tartrate (DET) and Ti(0-i-Pr)4], Kagan and co-workers46 and Modena and co-workers47 developed almost at the same time two variations of this reaction leading to o.p. sulfoxides with high enantiomeric purity. 

Most applications of sulfide oxidations by alkyl hydroperoxides have involved titanium catalysis together with chiral ligands for enantioselective transformations. The groups of Kagan in Orsay [61] and Modena in Padova [62] reported independently on the use of chiral titanium complexes for the asymmetric sulfoxidation by the use of BuOOH as the oxidant. A modification of the Sharpless reagent with the use of Ti(0 Pr)4 and (J ,J )-diethyl tartrate (J ,J )-DET) afforded chiral sulfoxides with up to 90% ee (Eq. (8.17)). 

---